Diversified [DHC] vs Global Medical REIT [GMRE] Detailed Stock Comparison
Diversified
NASDAQ
Loading...
Global Medical REIT
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Diversified wins in 9 metrics, Global Medical REIT wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Diversified | Global Medical REIT | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -2.25 | 95.29 | Diversified |
| Price-to-Book Ratio | 0.44 | 1.04 | Diversified |
| Debt-to-Equity Ratio | 143.14 | 138.39 | Global Medical REIT |
| PEG Ratio | 0.31 | -1.19 | Global Medical REIT |
| EV/EBITDA | 14.00 | 14.53 | Diversified |
| Profit Margin (TTM) | -18.83% | 7.25% | Global Medical REIT |
| Operating Margin (TTM) | -1.93% | 23.61% | Global Medical REIT |
| EBITDA Margin (TTM) | N/A | 23.61% | N/A |
| Return on Equity | -14.32% | 1.93% | Global Medical REIT |
| Return on Assets (TTM) | -0.54% | 1.67% | Global Medical REIT |
| Free Cash Flow (TTM) | $112.22M | $-25.07M | Diversified |
| Dividend Yield | N/A | 13.23% | N/A |
| 1-Year Return | 8.57% | -21.60% | Diversified |
| Price-to-Sales Ratio (TTM) | 0.54 | 6.39 | Diversified |
| Enterprise Value | $3.33B | $1.25B | Diversified |
| EV/Revenue Ratio | 2.19 | 8.83 | Diversified |
| Gross Profit Margin (TTM) | 18.33% | 78.31% | Global Medical REIT |
| Revenue per Share (TTM) | $6 | $2 | Diversified |
| Earnings per Share (Diluted) | $-1.20 | $0.07 | Global Medical REIT |
| Beta (Stock Volatility) | 2.51 | 1.19 | Global Medical REIT |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Diversified vs Global Medical REIT Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Diversified | 6.74% | 12.76% | 7.65% | 26.25% | 57.68% | 67.40% |
| Global Medical REIT | 4.71% | 9.90% | 3.09% | 18.99% | -13.15% | -3.43% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Diversified | 8.57% | 138.99% | -2.81% | -76.25% | -83.73% | -79.31% |
| Global Medical REIT | -21.60% | -35.08% | -43.48% | 6,008.33% | -90.84% | -90.84% |
Performance & Financial Health Analysis: Diversified vs Global Medical REIT
| Metric | DHC | GMRE |
|---|---|---|
| Market Information | ||
| Market Cap | $815.98M | $907.10M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 570,026 | 801,910 |
| 90 Day Avg. Volume | 935,942 | 672,307 |
| Last Close | $3.80 | $7.33 |
| 52 Week Range | $2.00 - $4.24 | $6.05 - $10.46 |
| % from 52W High | -10.38% | -29.92% |
| All-Time High | $29.99 (May 20, 2013) | $130.00 (Nov 10, 2014) |
| % from All-Time High | -87.33% | -94.36% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.03% | 0.11% |
| Quarterly Earnings Growth | 0.03% | 0.11% |
| Financial Health | ||
| Profit Margin (TTM) | -0.19% | 0.07% |
| Operating Margin (TTM) | -0.02% | 0.24% |
| Return on Equity (TTM) | -0.14% | 0.02% |
| Debt to Equity (MRQ) | 143.14 | 138.39 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $7.68 | $6.40 |
| Cash per Share (MRQ) | $0.59 | $0.25 |
| Operating Cash Flow (TTM) | $89.11M | $71.24M |
| Levered Free Cash Flow (TTM) | $65.02M | $68.51M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 13.23% |
| Last 12-Month Dividend | N/A | $0.84 |
Valuation & Enterprise Metrics Analysis: Diversified vs Global Medical REIT
| Metric | DHC | GMRE |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -2.25 | 95.29 |
| Forward P/E | -3.67 | 83.38 |
| PEG Ratio | 0.31 | -1.19 |
| Price to Sales (TTM) | 0.54 | 6.39 |
| Price to Book (MRQ) | 0.44 | 1.04 |
| Market Capitalization | ||
| Market Capitalization | $815.98M | $907.10M |
| Enterprise Value | $3.33B | $1.25B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.19 | 8.83 |
| Enterprise to EBITDA | 14.00 | 14.53 |
| Risk & Other Metrics | ||
| Beta | 2.51 | 1.19 |
| Book Value per Share (MRQ) | $7.68 | $6.40 |
Financial Statements Comparison: Diversified vs Global Medical REIT
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | DHC | GMRE |
|---|---|---|
| Revenue/Sales | $386.86M | $37.88M |
| Cost of Goods Sold | $314.33M | $8.22M |
| Gross Profit | $72.54M | $29.66M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-4.79M | $8.35M |
| EBITDA | $65.66M | $23.68M |
| Pre-Tax Income | $-10.42M | $585,000 |
| Income Tax | $49,000 | N/A |
| Net Income (Profit) | $-8.99M | $585,000 |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | DHC | GMRE |
|---|---|---|
| Cash & Equivalents | $302.58M | $5.41M |
| Total Current Assets | $386.39M | $17.03M |
| Total Current Liabilities | $26.93M | $698.69M |
| Long-Term Debt | $2.80B | $29.39M |
| Total Shareholders Equity | $1.95B | $538.10M |
| Retained Earnings | $-2.68B | $-305.68M |
| Property, Plant & Equipment | N/A | $11.03M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | DHC | GMRE |
|---|---|---|
| Operating Cash Flow | $77.27M | $13.54M |
| Capital Expenditures | N/A | $-31.98M |
| Free Cash Flow | $-3.24M | $-22.32M |
| Debt Repayment | $-239.40M | $-13.66M |
| Common Stock Repurchase | $-6,000 | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | DHC | GMRE |
|---|---|---|
| Shares Short | 5.02M | 2.49M |
| Short Ratio | 4.45 | 3.50 |
| Short % of Float | 0.04% | 0.04% |
| Average Daily Volume (10 Day) | 570,026 | 801,910 |
| Average Daily Volume (90 Day) | 935,942 | 672,307 |
| Shares Outstanding | 241.27M | 66.87M |
| Float Shares | 186.25M | 62.81M |
| % Held by Insiders | 0.10% | 0.06% |
| % Held by Institutions | 0.79% | 0.69% |
Dividend Analysis & Yield Comparison: Diversified vs Global Medical REIT
| Metric | DHC | GMRE |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.84 |
| Last 12-Month Dividend Yield | N/A | 13.23% |
| 3-Year Avg Annual Dividend | N/A | $0.77 |
| 3-Year Avg Dividend Yield | N/A | 2.29% |
| 3-Year Total Dividends | N/A | $2.31 |
| Ex-Dividend Date | N/A | Mar 21, 2025 |